Tag Archives: Cytokinetics

Cytokinetics Shares are Jumping. Its Heart Drug Looks Better than Ever  Barron’s Cytokinetics Skyrockets On ‘Provocative’ Results In Heart Disease  Investor’s Business Daily Cytokinetics drug yielded benefits over common therapy in patients with heart condition, study shows  statnews.com Cytokinetics: Game-Changing Data Confirms Best-In-Class Potential (NASDAQ:CYTK)  Seeking Alpha Promising Phase 3 Trial Results Bolster Buy Rating for Cytokinetics’ Aficamten  TipRanks Source link

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast The Readout Loud and author of the newsletter Adam’s Biotech Scorecard. You can reach Adam on Signal at stataf.54. An experimental medicine from Cytokinetics improved exercise capacity more than …